Agreement will aid drug discovery scientists

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, has signed a partnership agreement with ChemAxon.

The partnership will focus on providing access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle through Certara’s D360, a solution for queries for, analysis of and visualisation of scientific data.  It is used by pharmaceutical and biotech companies to provide unified access to disparate data sources throughout drug discovery and development, greatly improving research productivity.

The agreement with ChemAxon provides the standard D360, support for ChemAxon’s popular chemical structure sketching tool, Marvin Sketch, and JChem Chemistry data cartridge, which are used by many drug discovery scientists across the industry.

'We are very pleased to partner with ChemAxon to provide Marvin and JChem integrations as a standard D360 product capability,' said Jonathan Feldman, vice president of scientific informatics at Certara, said.

'Part of the value of D360 is being able to easily connect to an organisation’s existing infrastructure, and we are increasingly finding that ChemAxon is part of the core chemistry infrastructure.  

'We are now able to seamlessly integrate and deliver other data types, such as biologic assay or preclinical safety data with chemistry data from ChemAxon via simple queries that any user can develop.'

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets


Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion